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ABSTRACT
Objective: To compare the reliability of ligase chain reaction (LCR) to polymerase chain reaction
(PCR) in detecting Chlamydia trachomatis endocervical infections.
Methods: We conducted a prospective study of 486 patients at risk for chlamydial infection of the
endocervix. We obtained two endocervical specimens from each patient and used LCR and PCR to
detect C. trachomatis. Discrepant results between the two techniques were resolved by repeat testing
and by testing for the major outer membrane protein (MOMP) gene, if necessary. We determined
the sensitivity, specificity, positive predictive value, and negative predictive value for each test, using
concordant results or MOMP gene results as the "gold standard."
Results: Of the 486 patients, 42 (8.6%) had evidence of C. trachomatis infection after resolution of
discrepant results. Of the 42 true positive specimens, 41 were positive by initial LCR and 38 were
positive by initial PCR. Of the 444 true negative specimens, none had a positive initial LCR result,
while 2 had a positive initial PCR test. Therefore, compared to the gold standard, LCR had a
sensitivity of 97.6% and specificity of 100%, while PCR had a sensitivity of 90% and a specificity of
99.5%. The positive and negative predictive values of LCR were 100% and 99.8%, respectively.
PCR had a positive predictive value of95% and a negative predictive value of99.1%. The difference
in sensitivity of LCR versus PCR was not statistically significant (P .125).
Conclusion: LCR and PCR perform equally well in detecting C. trachomatis endocervical infec-
tions. Infect. Dis. Obstet. Gynecol. 6:57-60, 1998. (C) 1998 Wiley-Liss, Inc.
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ulture in mammalian cell lines has been con-
sidered the "gold standard" for diagnosing
Calamydia tracaomatis; however, this method is la-
bor intensive, time consuming, and expensive.
Non-culture methods, including direct fluorescent
antibody (DFA) testing and enzyme immunoas-
says, have been employed but lack the sensitivity
and specificity of tissue culture. More recently,
DNA amplification techniques, including the poly-
merase chain reaction (PCR)-based Amplicor (7.
tracaomatis Test (Roche Molecular Systems,
Branchburg, NJ) and the ligase chain reaction
(LCR)-based LCx Probe System (Abbott Labora-
tories, Chicago, IL), have been used to diagnose
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urogenital chlamydial infections with improved
sensitivity, e,-
To our knowledge, two studies have been pub-
lished comparing LCR to PCR in the detection of
chlamydial infections of the urogenital tract. In the
first study, de Barbeyrac et al.4 found LCR to be
more sensitive than PCR in the diagnosis of endo-
cervical and urethral chlamydial infections; the dif-
ference in sensitivity was not statistically signifi-
cant. In the second study, Pasternack et al.s like-
wise could find no statistically significant
difference between LCR and PCR; however, they
believed the manual PCR was superior to LCR,
because only the manual PCR correctly identified
all chlamydia-positive patients. The purpose of our
study was to determine if either LCR or PCR was
superior in detecting C. trachomatis endocervical in-
fections.
SUBJECTS AND METHODS
Between April and July 4, 1996, we obtained two
endocervical specimens from 486 women seen at
the University of Florida Shands Hospital who
were at risk for chlamydial infection. Specimens
were obtained from new obstetric patients; gyne-
cologic patients with pelvic pain, mucopurulent
cervical discharge, or other signs or symptoms pos-
sibly attributable to chlamydia infection; and all
reproductive-aged women seen in the Emergency
Department regardless of their chief reason for
seeking treatment. We conducted this study under
a protocol approved by the Institutional Review
Board.
To obtain specimens, examiners first removed
any cervical discharge with a large cotton swab.
They then sampled the endocervical canal sequen-
tially with two Dacron swabs, rotating each swab
for 15-30 seconds to ensure adequate sampling.
They placed and left the swab for LCR testing into
the LCR transport media. The examiners vigor-
ously swirled the swab for PCR testing in the PCR
transport media, expressed excess fluid, and re-
moved the swab in accordance with the manufac-
turer’s instructions. The specimens were kept at
room temperature and transported to the laboratory
within 12 hours of collection and kept refrigerated
for not more than 48 hours prior to testing. Labo-
ratory personnel were blinded to the LCR and
PCR results for each matched pair until the final
result for each method was determined. After test-
ing, specimens were held frozen at-70C in case
further studies needed to be performed.
The LCx Probe System uses four primers with
specificity for the C. trachomatis cryptic plasmid.
Laboratory technicians performed this test after di-
rect training from the manufacturer using methods
previously described.3 Briefly, the specimen was
first heat denatured at 97C for 15 minutes and 100
pl was added to amplification vials containing all
reagents for amplification. The amplification was
carried out in a thermocycler for 40 cycles, and the
entire run was transferred to the analyzer which
adds all reagents for the detection of the amplified
product. The amplification and detection steps
were performed in a physically separate area from
the setup of new specimens. All test runs included
appropriate calibrators, together with positive and
negative controls provided by the manufacturer.
PCR was performed according to the instruc-
tions from the manufacturer as previously de-
scribed, e In this procedure, ml of Specimen Dil-
uent was added to the patient specimen and 50 pl
of the mixture was added to the PCR tube contain-
ing the PCR Master Mix. After 30 cycles of thermal
amplification in the presence of biotin labeled
primers also directed towards the C. trachomatis
cryptic plasmid, the reaction mixture was trans-
ferred to a microtiter plate coated with a DNA cap-
ture probe. The amplified product was then de-
tected with the addition of avidin-horseradish per-
oxidase in an ELISA format. Thermocycling was
carried out with Uracil-N-glycosylase to prevent
carryover contamination. As specified by the manu-
facturer, one positive control and one negative con-
trol tested in triplicate were included with each test
run.
All specimens testing within the equivocal range
for either method were repeated twice. None of
the PCR results were equivocal. Only two of the
LCR results were in the equivocal range. On re-
peat testing, one specimen was positive and one
was negative.
Any specimen that tested positive by one
method but not by the other was tested again by
both methods, and all such discrepant specimens
were sent to the Roche and Abbott laboratories
under code for repeat testing and resolution using
primers for the major outer membrane protein
(MOMP) gene, if necessary. We calculated the sen-
sitivity, specificity, and positive and negative pre-
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TABLE I. Resolution of discrepant results at Abbott and Roche Laboratories
Case Initial Initial Resolved LCR
number LCR result PCR result result (Abbott)
Resolved PCR Final
result (Roche) diagnosis
+ +
2 + + +
3 + + +
4 + + +
5 + + Not done*
6 /
7 +
*The remaining PCR specimen was accidentally discarded.
dictive values for both tests using concordant re-
suits on initial or repeat testing or MOMP gene
results for persistently discordant tests as the gold
standard. We then performed an exact form of the
McNemar test to determine if the difference in
sensitivities of the two tests was significant.
RESULTS
Of the 486 patients, 442 tested negative initially by
both tests, while 37 patients were positive initially
by both LCR and PCR. Seven patients had discor-
dant initial LCR and PCR results (Table 1). Four
patients were positive by LCR and negative by
PCR (cases 1-4). Repeat testing in our laboratory
confirmed these results. Upon duplicate .testing on
undiluted specimens at the outside laboratories, all
four PCR specimens tested positive; the LCR re-
suits remained unchanged. Three patients were
negative by LCR and positive by PCR (cases 5-7).
Repeat testing in our laboratory confirmed the ini-
tial results. Two of these patients (numbers 6 and
7) had both negative LCR and PCR tests on undi-
luted specimens at the outside laboratories (initial
false-positive PCR tests). The remaining patient
(number 5) tested positive by LCR when the test
was repeated on an undiluted specimen (initial
false negative LCR). Testing for the MOMP gene
was not required to resolve discrepancies on any
specimens.
Of the 486 patients, 42 (8.6%) had evidence of
C. trachomatis infection after resolution of discrep-
ant results. Of the 42 true positive specimens, 41
tested positive by initial LCR and 38 tested posi-
tive by initial PCR. Of the 444 specimens negative
by both methods on initial or repeat testing, none
had a positive initial LCR result, while two had a
positive initial PCR result. Therefore, using the
resolved results as the gold standard, LCR had a
sensitivity and specificity of 97.6% and 100%, re-
spectively, while PCR had a sensitivity of 90% and
a specificity of 99.5%. The positive and negative
predictive values of LCR were 100% and 99.8%,
respectively. PCR had a positive predictive value
of 95% and a negative predictive value of 99.1%.
The difference in sensitivity of LCR versus PCR
was not statistically significant (P .125).
DISCUSSION
LCR and PCR techniques both utilize DNA am-
plification technology, and both methods are more
sensitive in diagnosing C. trachomatis endocervicitis
than older methods, such as culture, DFA, or
ELISA. In this head to head comparison using en-
docervical specimens, the original LCR result
proved to be correct in six of the seven discordant
pairs while the original PCR result was correct in
only one pair. The difference in performance of
LCR versus PCR was not statistically significant.
In a study of over 2,000 patients, Schachter et al.
compared LCR to cell culture for the diagnosis of
C. trachomatis endocervicitis using endocervical
specimens and found the sensitivity of LCR was
94% versus 65% for culture. These authors con-
cluded LCR was a highly sensitive method for de-
tecting C. trachomatis endocervicitis and called for a
direct comparison between LCR and PCR to de-
termine which test was better. The first such study
was published by de Barbeyrac et al.,4 who studied
134 women from a low-risk population and 84
women and 62 men from a high-risk population. In
the female group, the authors compared the per-
formance of LCR, PCR, and tissue culture using
endocervical specimens. A specimen was consid-
ered truly positive if the culture was positive, if the
LCR and PCR were both positive, or if the MOMP
gene was positive when the LCR and PCR results
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were discordant. A specimen was truly negative if
the culture and either the LCR or PCR were nega-
tive. The sensitivity of LCR was 95.2% versus
80.9% for both PCR and culture; the specificity of
both LCR and PCR was 99.6%. The difference in
sensitivity of LCR versus PCR was not statistically
significant. The authors concluded LCR was a
good alternative to PCR in the detection of chla-
mydial infections.
Pasternack et al.s recently compared the results
of LCR and PCR on first void urine specimens to
tissue culture on endocervical specimens in the de-
tection of C. trachomatis infections in 442 female
patients. Positive culture, positive LCR and PCR
results, and a positive MOMP gene test when the
LCR and PCR results were discordant were con-
sidered truly positive. In their study, PCR had a
sensitivity of 100% and specificity of 99.7%, while
the sensitivity and specificity ofLCR was 94% and
100%, respectively. Again, the difference in sensi-
tivity between the two tests was not statistically
significant. However, the authors believed the
manual PCR was better than LCR because the
manual PCR detected all chlamydia-positive pa-
tients.
As with the above reports, our study did not
demonstrate a statistically significant difference in
the performance of LCR versus PCR. However,
after resolution of the discordant specimens, the
original LCR result proved to be correct in six of
the seven discordant pairs while the initial PCR
result was correct only once. In our study, there was
a single false-negative LCR and four false-negative
PCR results. These false-negative results may have
been caused by ligase or polymerase inhibitors, a
problem to which both DNA amplification tests are
susceptible. 1,6 We cannot confirm this since we did
not perform any specific tests to determine if in-
hibiting factors were present. Whether LCR is pos-
sibly less sensitive to inhibitors must await further
study.
A limitation of our study is that we did not ob-
tain specimens for confirmatory tissue culture.
Therefore, it is possible that some of our concor-
dant pairs were both falsely positive or both falsely
negative and our calculated sensitivities and speci-
ficitie are overestimates. This would be a serious
drawback to our study if our purpose was to deter-
mine the exact sensitivity and specificity of LCR
and PCR. However, our purpose was to directly
compare the relative performance of two tests
which have already been shown to be more sensi-
tive and nearly as specific as tissue culture. DNA
amplification tests are reported to be greater than
90% sensitive and greater than 99% specific, while
tissue culture is typically 75-85% sensitive and
considered 100% specific.3-7 While our calculated
sensitivities and specificities may be overestimates
of the true values for both LCR and PCR, the
number and nature of the discordant pairs are un-
affected. Therefore, even though we did not obtain
confirmatory tissue cultures, the relative perfor-
mance of LCR versus PCR, and the results of our
study, are unchanged.
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